Aileron Therapeutics, Inc. (ALRN) has a market capitalization of $45.72M and trades at $2.11. The 52-week range is 1.61-7.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-1.96.
The stock has a beta of 2.34, operates in the Healthcare sector.
